Beurs gesloten -
BME
17:35:25 07-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
6,385
EUR
|
-1,47%
|
|
+6,33%
|
-39,48%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
18.760
|
14.161
|
9.783
|
6.557
|
9.231
|
5.561
|
-
|
-
|
Bedrijfswaarde
1 |
25.225
|
20.597
|
16.478
|
15.716
|
18.568
|
14.659
|
14.142
|
13.742
|
K/w-verhouding
|
34,5
x
|
26,5
x
|
62,5
x
|
34,7
x
|
172
x
|
12,3
x
|
8,45
x
|
7,18
x
|
Dividendrendement
|
1,15%
|
0,71%
|
2,13%
|
-
|
-
|
0%
|
2,26%
|
5,54%
|
Marktkapitalisatie/omzet
|
3,68
x
|
2,65
x
|
1,98
x
|
1,08
x
|
1,4
x
|
0,78
x
|
0,73
x
|
0,69
x
|
Bedrijfswaarde/omzet
|
4,95
x
|
3,86
x
|
3,34
x
|
2,59
x
|
2,82
x
|
2,07
x
|
1,85
x
|
1,71
x
|
Bedrijfswaarde/EBITDA
|
17,9
x
|
13,9
x
|
17,1
x
|
12,9
x
|
12,8
x
|
8,1
x
|
6,67
x
|
6,09
x
|
Bedrijfswaarde/FCF
|
161
x
|
25,7
x
|
52,1
x
|
-56,7
x
|
-213
x
|
27,6
x
|
20,6
x
|
15,7
x
|
FCF Yield
|
0,62%
|
3,9%
|
1,92%
|
-1,76%
|
-0,47%
|
3,62%
|
4,86%
|
6,36%
|
Price to Book
|
4,46
x
|
1,99
x
|
1,89
x
|
1,19
x
|
1,79
x
|
0,91
x
|
0,83
x
|
0,71
x
|
Aantal aandelen (in duizenden)
|
684.135
|
684.540
|
682.484
|
678.911
|
678.665
|
679.092
|
-
|
-
|
Referentieprijs
2 |
31,43
|
23,88
|
16,88
|
10,77
|
15,46
|
9,286
|
9,286
|
9,286
|
Datum van publicatie
|
27/02/20
|
26/02/21
|
28/02/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
5.099
|
5.340
|
4.933
|
6.064
|
6.592
|
7.097
|
7.641
|
8.033
|
EBITDA
1 |
1.407
|
1.479
|
961,5
|
1.221
|
1.455
|
1.810
|
2.122
|
2.258
|
Bedrijfsresultaat (EBIT)
1 |
1.131
|
996,1
|
595,1
|
805,7
|
1.023
|
1.290
|
1.585
|
1.648
|
Operationele Marge
|
22,19%
|
18,65%
|
12,06%
|
13,29%
|
15,52%
|
18,17%
|
20,74%
|
20,51%
|
Resultaat voor belastingen (EBT)
1 |
817,1
|
878,6
|
350,5
|
361,3
|
224
|
738,2
|
1.102
|
1.133
|
Nettowinst (verlies)
1 |
625,1
|
618,5
|
182,8
|
208,3
|
59,32
|
468,3
|
721,8
|
821,6
|
Nettomarge
|
12,26%
|
11,58%
|
3,71%
|
3,43%
|
0,9%
|
6,6%
|
9,45%
|
10,23%
|
WPA
2 |
0,9100
|
0,9000
|
0,2700
|
0,3100
|
0,0900
|
0,7570
|
1,099
|
1,294
|
Free Cash Flow
1 |
156,6
|
802,2
|
316,1
|
-277,4
|
-87,14
|
530,2
|
687,5
|
873,4
|
FCF-marge
|
3,07%
|
15,02%
|
6,41%
|
-4,57%
|
-1,32%
|
7,47%
|
9%
|
10,87%
|
Kasstroomconversie (ebitda)
|
11,13%
|
54,24%
|
32,87%
|
-
|
-
|
29,29%
|
32,4%
|
38,68%
|
Kasstroomconversie (nettowinst)
|
25,05%
|
129,7%
|
172,91%
|
-
|
-
|
113,23%
|
95,25%
|
106,3%
|
Dividend per aandeel
2 |
0,3600
|
0,1700
|
0,3600
|
-
|
-
|
0,000100
|
0,2102
|
0,5140
|
Datum van publicatie
|
27/02/20
|
26/02/21
|
28/02/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020 S1
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2021 S2
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Omzet
1 |
2.677
|
2.537
|
1.198
|
1.198
|
2.396
|
1.405
|
1.543
|
2.810
|
1.541
|
1.713
|
3.254
|
1.561
|
1.663
|
3.225
|
1.597
|
1.770
|
1.640
|
1.765
|
1.747
|
1.840
|
EBITDA
1 |
731,4
|
634,5
|
-
|
-
|
327
|
248,2
|
-
|
618,3
|
308
|
294
|
602,7
|
298,8
|
360,7
|
659,5
|
373,6
|
426,3
|
366,4
|
459,4
|
456,1
|
-
|
Bedrijfsresultaat (EBIT)
1 |
421,7
|
463,6
|
-
|
-
|
131,5
|
-
|
-
|
427,3
|
173,4
|
176,9
|
378,3
|
175,7
|
253,6
|
-
|
264,4
|
329,3
|
229,5
|
339,2
|
336
|
-
|
Operationele Marge
|
15,75%
|
18,27%
|
-
|
-
|
5,49%
|
-
|
-
|
15,21%
|
11,25%
|
10,33%
|
11,63%
|
11,25%
|
15,25%
|
-
|
16,55%
|
18,61%
|
13,99%
|
19,22%
|
19,23%
|
-
|
Resultaat voor belastingen (EBT)
1 |
-
|
378,2
|
-
|
-
|
-27,78
|
-
|
-
|
227,9
|
66,69
|
46,88
|
133,4
|
-84,17
|
103,2
|
19,05
|
99,59
|
105,4
|
55,02
|
69,75
|
81,75
|
107,2
|
Nettowinst (verlies)
1 |
218,2
|
266,8
|
-
|
-
|
-84,01
|
-
|
-
|
143,6
|
45
|
20,07
|
64,63
|
-108,3
|
52,04
|
-56,22
|
59,54
|
55,99
|
32,79
|
71,22
|
77,38
|
68,76
|
Nettomarge
|
8,15%
|
10,52%
|
-
|
-
|
-3,51%
|
-
|
-
|
5,11%
|
2,92%
|
1,17%
|
1,99%
|
-6,93%
|
3,13%
|
-1,74%
|
3,73%
|
3,16%
|
2%
|
4,04%
|
4,43%
|
3,74%
|
WPA
2 |
-
|
0,3900
|
-0,0600
|
-
|
-0,1200
|
-
|
-
|
0,2100
|
-
|
-
|
0,1000
|
-
|
0,0800
|
-
|
-
|
-
|
0,0665
|
0,1762
|
0,1725
|
0,0515
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
30/07/20
|
29/07/21
|
28/02/22
|
28/02/22
|
28/02/22
|
28/07/22
|
28/07/22
|
28/07/22
|
8/11/22
|
28/02/23
|
28/02/23
|
9/05/23
|
27/07/23
|
27/07/23
|
2/11/23
|
28/02/24
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
6.465
|
6.436
|
6.695
|
9.158
|
9.337
|
9.098
|
8.581
|
8.181
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
4,595
x
|
4,352
x
|
6,963
x
|
7,501
x
|
6,419
x
|
5,027
x
|
4,044
x
|
3,623
x
|
Free Cash Flow
1 |
157
|
802
|
316
|
-277
|
-87,1
|
530
|
687
|
873
|
ROE (netto-inkomsten/eigen vermogen)
|
15,9%
|
12,5%
|
3,26%
|
3,57%
|
3,72%
|
9,02%
|
11,2%
|
11,5%
|
ROA (netto-inkomsten/totale activa)
|
5,13%
|
4,01%
|
1,06%
|
1,02%
|
1,04%
|
2,14%
|
3,07%
|
3,06%
|
Totale activa
1 |
12.193
|
15.409
|
17.254
|
20.384
|
5.701
|
21.931
|
23.490
|
26.817
|
Nettoactief per aandeel
2 |
7,050
|
12,00
|
8,950
|
9,040
|
8,640
|
10,30
|
11,20
|
13,00
|
Cashflow per aandeel
2 |
0,8300
|
1,620
|
0,8800
|
-0,0200
|
0,3100
|
1,050
|
1,480
|
1,570
|
Capex
1 |
412
|
308
|
281
|
266
|
295
|
435
|
368
|
379
|
Capex/omzet
|
8,09%
|
5,77%
|
5,69%
|
4,39%
|
4,48%
|
6,12%
|
4,82%
|
4,72%
|
Datum van publicatie
|
27/02/20
|
26/02/21
|
28/02/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
9,286
EUR Gemiddelde koersdoel
17,27
EUR Spread / Gemiddelde doel +86,01% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -2,47% | 88,14 mld. | | +3,29% | 40,44 mld. | | -15,40% | 32,24 mld. | | +51,96% | 24,39 mld. | | -14,35% | 15,59 mld. | | -39,65% | 12,3 mld. | | -6,52% | 12,18 mld. | | -13,41% | 12,14 mld. | | +5,17% | 8,87 mld. |
Biofarmaceutica
|